Inflows Into Hyperliquid ETFs Have Reversed. Should Investors Be Concerned?

Hyperliquid-focused crypto ETFs (Grayscale HYPG, Bitwise BHYP, 21Shares THYP) launched strongly but ETF flow momentum is “drying up,” with assets rising to ~$113M at Grayscale and $150M+ across the two newer competitors despite their short lifetimes. The article attributes weaker flows to intensified competition in perpetual futures (“perps”), including the risk that traders shift to more centralized, potentially U.S.-regulated platforms. While Hyperliquid fees have supported token buybacks and prediction-market developments could help, near-term inflows into these regulated ETF products may be harder to sustain.

Analysis

The market is starting to distinguish between “crypto beta” and “venue share.” If perpetual futures trading migrates toward regulated centralized platforms, the economic loop that supports HYPE — fee generation feeding buybacks, buybacks supporting token price, token price supporting ETF narrative — weakens at the margin. That is a second-order negative for HYPG/THYP flows because these products need a clean, durable growth story; once investors doubt the moat, creations can stall even without a sharp drawdown in the underlying token.

Near term, the key catalyst path is not price action but product announcements: any U.S.-regulated perp launch, exchange incentive program, or brokerage integration could pressure Hyperliquid’s share within weeks to months. The structural risk is slower but more important: if the trade shifts from decentralized execution to compliance and access, Hyperliquid may still grow, but at a lower take-rate and with less incremental scarcity, compressing the reflexive valuation premium. That would matter more for holders than for ETF sponsors, whose AUM is still too small for this to be a standalone earnings story.

The contrarian view is that the market may be overreading weak ETF momentum as a HYPE-specific demand failure when it may simply reflect the early adopter cohort exhausting itself. If Hyperliquid can broaden beyond perps into marginable multi-product workflows for professional traders, the current flow slowdown could prove temporary. The falsifier is straightforward: sustained AUM stabilization plus renewed daily volume share would invalidate the “competition is taking share” narrative; absent that, this is a wait-and-see, not a buy-the-dip setup.

Key Decisions for Investors

• Avoid initiating fresh longs in HYPG/THYP for now; wait for 2-3 consecutive weekly flow prints to stabilize before adding. If redemptions persist and HYPE volume share slips further, short HYPG tactically for 4-8 weeks with a stop on a renewed >20% HYPE rally or a major regulated-perps launch.
• Pair trade idea: short HYPG or THYP against long COIN or CME over 1-3 months to express the migration of derivatives activity toward regulated venues. Target 10-15% relative underperformance if U.S.-regulated perps gain traction; exit if Hyperliquid announces material multi-product adoption.
• For existing HYPE exposure, reduce outright delta or use a collar into the next catalyst window. The upside is still open if prediction-market utility broadens, but the risk/reward has shifted from reflexive squeeze to slower fundamental compounding.
• Set a watchlist alert on any U.S. exchange/perp product rollout or regulatory approval. That is the key falsifier for the short-HYPG thesis and could force a rapid reassessment within days, not months.